ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag coronary heart disease cell molecular biology ecology microbiology

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Notebook
The Scientist Staff | Feb 14, 1999 | 5 min read
Editor's Note: The news items on this page all originated from the American Association for the Advancement of Science annual meeting in Anaheim, Calif., Jan. 21-26. PLAQUE ATTACK A host of studies have bitten off the task of linking periodontitis with coronary heart disease. But without more evidence, scientists may find any cause-and-effect relationship between tooth disease and heart attacks hard to swallow, admitted James D. Beck, professor of dental ecology, at the University of North Caro
News feature
Vector image of black body with head surrounded by white clouds
Multiple Possible Causes of Long COVID Come into Focus
Natalia Mesa, PhD | Sep 28, 2022 | 10+ min read
Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Picturing Infection
Kelly Rae Chi | Jan 1, 2015 | 7 min read
Whole-animal, light-based imaging of infected small mammals
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.
Homing In On Homocysteine
Ricki Lewis | Jan 23, 2000 | 9 min read
Peruse the aisles of any supermarket, and the message that cholesterol causes heart disease rings loud and clear. But soon attention will likely shift to another culprit: homocysteine. This amino acid is usually scant in the blood. But when slightly elevated, it may set the stage for the atherosclerosis that is so tightly linked to cholesterol. Controlling homocysteine level is a simple matter of taking more vitamins--folic acid in particular. Donald Jacobsen "In the future, a homocysteine
Soybeans Hit Main Street
Barry Palevitz | Mar 19, 2000 | 8 min read
Once a favorite of Chinese emperors, tofu is now big time. From supermarkets to health food boutiques, diet-conscious Americans are buying soybeans, not just as tofu but in infant formula, soy milk, and soy burgers. Soy even has the Food and Drug Administration's seal of approval. Last October the FDA responded to a petition by Protein Technologies International, a St. Louis-based DuPont company specializing in soy products, by authorizing claims that soy protein is good for the heart. Acc

Run a Search

ADVERTISEMENT